Frequently Asked Questions

What Is Dr Alivio Topical Analgesic?
A highly advanced Patent Pending pain cream developed to provide maximum relief obtainable.

Why Was DR. ALIVIO™ Topical Analgesic Created?
Dr. Morgan's development of DR. ALIVIO™ Topical Analgesic formulation was for his mother-in-law who suffered from painful symptoms in her feet caused by Idiopathic Neuropathy, which was diagnosed by her Neurologist.

Who Is Dr. Morgan
An individual who dedicates a little extra effort in creating simple solutions to painful situations.

How Often Should I Apply DR. ALIVIO™ Topical Analgesic?
It is CC Medical Devices, Inc. suggestion to apply a minimum of 2 times daily.  The reasoning is that often individuals with high pain tolerances don’t feel the underlying symptoms that cause the pain.

How Much Of The DR. ALIVIO™ Topical Analgesic Should Be Applied?
It is suggested that ¼ teaspoon per each 4 inch by 4 inch area be used to
start, the amount may be varied to obtain personal results.  Pain perception
is an individual characteristic.  It is also suggested to apply DR. ALIVIO™ Topical
Analgesic approximately 3 to 4 inches outside of the area of pain due to the parallel flow of tissue fluids.

How Does The Amount Used Effect The Intensity Of The Sensation and Results of Temporary Relief?
The greater the thickness applied to an area the greater the volume of active
ingredients placed in that area.

What If The Sensation Becomes Too Intense?
Wash off using cool water, this will solidify the compound so that it may be more easily removed.

Will I Feel The Sensation As Hot Or Cold?
CC Medical Devices, Inc. does not know why some individuals feel a Cold sensation while other experience a Hot sensation, although it has been noticed that a Hot sensation occurs much more often in individuals than the Cold sensation.

Reasons To Prefer DR. ALIVIO™ Topical Analgesic Over Other Products.
Dr Alivio Topical Analgesic products are created using a Patent Pending formulation that enhances the ability for its active ingredients to perform their function, by creating a small chemical-electrical charge by combining metabolic waste secretions due to tissue stress with the added ingredients in Dr Alivio Topical Analgesic.  This approach allows for the active ingredients to also reactivate at a later date when tissues become stressed when not washed or wiped off the involved area.

Questions For Dr. Morgan
Due to past history of forum traffic and time for researching topic, Dr. Morgan
accepts two questions per week on a first come basis.

How DR. ALIVIO™ Topical Analgesic Out Performs Other Products.
The Patent Pending formulation enhances the active ingredients involved with
providing Temporary Relief.

Let Us Demonstrate DR. ALIVIO™ Topical Analgesic.
Dr Alivio Topical Analgesic ability and performance has been demonstrated using
Patient’s Subjective Reviews, Microscopic Visual Observation, Voltmeters, Thermal Images

Demonstrating DR. ALIVIO™ Topical Analgesic Using Voltmeters.
A voltmeter has been used to measure intensity as well as longevity of the
temporary relief. Intensity has a direct correlation as to the millivolts produced
upon activation within a 15 minute time period.  Longevity is measured on how
long millivolts are produced at a level that may be perceived by an individual,
while in a moisturized environment.  This technique was also used during
development to demonstrate superior performance against competitors
formulations for Topical Pain Relieving Products.

Demonstrating DR. ALIVIO™ Topical Analgesic Using A Microscope.
When DR. ALIVIO™ Topical Analgesic is activated after applying to a individual experiencing pain and placed under a microscope there is an occurance of
movement due to the chemical-electrical response between the metabolic waste
and the formulation.

Demonstrating DR. ALIVIO™ Topical Analgesic Using Thermal Images.
After applying DR. ALIVIO™ Topical Analgesic to an area where individuals are experiencing pain it has been observed an increase in vascular function occurs as a much greater rate using than those using the same active ingredients without the Patent Pending formulation additives.

Demonstrating DR. ALIVIO™ Topical Analgesic Using A Time-Lapsed Photography.
While comparing Topical Analgesic Creams containing the same active ingredients and DR. ALIVIO™ Patent Pending formulation using Thermal Camera Images, DR. ALIVIO™ demonstrated greater vascular function than others.

Demonstrating DR. ALIVIO™ Topical Analgesic Using Inclinometers.
Using FDA approved Inclinometer equipment to demonstrate joint mobility
under xxx guidelines often movement is increased due to lessened nerve
perception due to the temporary relief provided by DR. ALIVIO™ Topical
Analgesic.  (Recorded measurements of “Before” and “After” application of
DR. ALIVIO™ Topical Analgesic)

Demonstrating DR. ALIVIO™ Topical Analgesic Using Patients Subjective
Verbalization.
After 50 minutes individuals respond with statements of “It is easier to move
my back” or “I don’t feel the pain nearly as much as before applying DR. ALIVIO™ Topical Analgesic to the area of pain.

Which DR. ALIVIO™ products should I use SILVER, GOLD, Platinum?
SILVER is a cosmetic grade of massage cream, not having levels of active
ingredients recognized by the FDA Monograph as being functional.  GOLD is
what we consider a medium grade of External Analgesic and is governed by
the FDA’s Monograph regulations for Topical Analgesic product for Over-The-
Counter use. Platinum is a what we consider an aggressive formulation in that
it contains the maximum level of active ingredients allowed by the FDA Monograph guidelines, which will be offered at a later date.

Temporary Relief Of Pain Descriptions

Users Respond As To The Pains They Relieved By Using DR. ALIVIO™
Topical Analgesic
“I almost forgot that I have arthritis”
“My pain from arthritis is much less within 15 minutes”
“I felt it working with in a few minutes and felt it reactivate 9 hours later.”
“The cream provided me with temporary relief from the pain caused by the
Diabetic Neuropathy experienced at night.  Now I am able to sleep at night.”
“Worked wonders on my low back pain.”
“I hardly notice the arthritis pain in my knee after using Dr. Alivio pain cream,
nice to walk virtually with no pain.”

Why DR. ALIVIO™ Topical Analgesic Does Not Contain Triple Bonded
Chemicals such as Triethanolamine.
It is the intent to distribute DR. ALIVIO™ Topical Analgesic into International
Markets.  Since Triethanolamine use has been prohibited in some countries
we have found it necessary not to use this Triple Bonded Chemical within
our formulation.

Why It Is Important To Provide DR. ALIVIO™ Topical Analgesic As An “Over
The Counter Product.
In today’s market of Prescription prices and the lack of insurance obtainable
by individuals we are very proud to provide such a quality Patent Pending
product at an affordable price to individuals in pain.

Dr Alivio Topical Analgesic Drug Facts box contents and wording.
It is our intention to walk through the information contained within the Drug
Facts box as to educate consumers on how to use the information.

What Makes DR. ALIVIO™ Topical Analgesic a Topical Analgesic per FDA.
CC Medical Devices, Inc. has followed the guidelines set forth by the FDA 1983
External Analgesic OTC (Over The Counter) tentative final monograph
guidelines 21 CFR part 348. http://www.fda.gov/cder/otcmonographs/External_Analgesic/new_external
_analgesic.htm

Is DR. ALIVIO™ Topical Analgesic Approved By The FDA?
No, External Analgesic products do no require approval by the FDA. 
Although FDA Monograph guidelines must be followed and registered with
the FDA. http://www.fda.gov/cder/guidance/4316dft.htm

Why Is DR. ALIVIO™ Topical Analgesic Manufactured in a cGMP (current Good Manufacturing Practice) facility.
A cGMP facility provides highest quality product obtainable for the consumer.
http://www.fda.gov/cder/regulatory/applications/compliance.htm

What Does the NDC (National Drug Code) number on DR. ALIVIO™ Topical
Analgesic containers mean to you?
“The Drug Listing Act of 1972 requires registered drug establishments to
provide the Food and Drug Administration (FDA) with a current list of all
drugs manufactured, prepared, propagated, compounded, or processed by
it for commercial distribution.  (See Section 510 of the Federal Food, Drug,
and Cosmetic Act (Act) (21 U.S.C. § 360)).”
http://www.fda.gov/cder/ndc/